| scholarly article | Q13442814 |
| P2093 | author name string | Toshiro Fujita | |
| Kazunori Kataoka | |||
| Nobuhiro Nishiyama | |||
| Koei Yamada | |||
| Kanjiro Miyata | |||
| Makoto Oba | |||
| Akira Yamada | |||
| Hideki Shimizu | |||
| Satoru Matsumoto | |||
| Shinya Kaname | |||
| Yuichi Hori | |||
| P2860 | cites work | IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis | Q28285105 |
| Strategies for silencing human disease using RNA interference | Q28288535 | ||
| p38 MAPK signalling cascades in inflammatory disease | Q28678986 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation. | Q33282855 | ||
| MAPK signaling and the kidney | Q34039916 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| Gene therapy in renal diseases. | Q35746821 | ||
| On future's doorstep: RNA interference and the pharmacopeia of tomorrow | Q36173624 | ||
| Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains | Q36342054 | ||
| Nonviral delivery of synthetic siRNAs in vivo | Q37024768 | ||
| Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. | Q37370413 | ||
| Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo | Q37383055 | ||
| Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference | Q37704644 | ||
| Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. | Q39983715 | ||
| Small RNAs: delivering the future | Q40144891 | ||
| Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney | Q40305917 | ||
| Therapeutic approach for diabetic nephropathy using gene delivery of translocase of inner mitochondrial membrane 44 by reducing mitochondrial superoxide production | Q40309743 | ||
| An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection | Q40347915 | ||
| Immunoliposome targeting to mesangial cells: a promising strategy for specific drug delivery to the kidney | Q40370419 | ||
| Extracellular signal-regulated kinase mediates stimulation of TGF-beta1 and matrix by high glucose in mesangial cells. | Q40839906 | ||
| Angiotensin II and vasopressin stimulate calcium-activated chloride conductance in rat mesangial cells | Q40919878 | ||
| Involvement of extracellular signal-regulated kinase 2 and stress-activated protein kinase/Jun N-terminal kinase activation by transforming growth factor beta in the negative growth control of breast cancer cells. | Q41127524 | ||
| Transforming growth factor beta activation of p44mapk in proliferating cultures of epithelial cells | Q41357904 | ||
| Autocrine secretion of transforming growth factor-beta in cultured rat mesangial cells | Q41590910 | ||
| Polyion complex micelles from plasmid DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer as serum-tolerable polyplex system: physicochemical properties of micelles relevant to gene transfection efficiency | Q41915421 | ||
| Monomolecular assembly of siRNA and poly(ethylene glycol)-peptide copolymers. | Q43692559 | ||
| Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells | Q43818212 | ||
| Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells | Q44489915 | ||
| In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. | Q44688666 | ||
| High ambient glucose enhances sensitivity to TGF-beta1 via extracellular signal--regulated kinase and protein kinase Cdelta activities in human mesangial cells. | Q45000512 | ||
| AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage | Q45104453 | ||
| Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs | Q45147309 | ||
| Polyion complex micelles as vectors in gene therapy--pharmacokinetics and in vivo gene transfer | Q45885280 | ||
| Preparation and characterization of size-controlled polymeric micelle containing cis-dichlorodiammineplatinum(II) in the core | Q47204839 | ||
| Inhibition of respiratory viruses by nasally administered siRNA. | Q47874231 | ||
| Supramolecular nanocarrier of siRNA from PEG-based block catiomer carrying diamine side chain with distinctive pKa directed to enhance intracellular gene silencing. | Q51596787 | ||
| Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. | Q53562530 | ||
| RNAi-mediated gene silencing in non-human primates. | Q53630565 | ||
| Cobalt promotes angiogenesis via hypoxia-inducible factor and protects tubulointerstitium in the remnant kidney model. | Q53659543 | ||
| Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(L-lysine) block copolymers. | Q54013679 | ||
| Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. | Q54471089 | ||
| Structure of the glomerular mesangium: a biomechanical interpretation | Q68632784 | ||
| Murine models of systemic lupus erythematosus | Q69894910 | ||
| Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin | Q70971602 | ||
| A sensitive method of non-radioactive in situ hybridization for mRNA localization within human renal biopsy specimens: use of digoxigenin labeled oligonucleotides | Q72032603 | ||
| Transforming growth factor beta 2 stimulates acute and chronic activation of the mitogen-activated protein kinase cascade in rat renal mesangial cells | Q72798764 | ||
| Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury | Q73338471 | ||
| Differential activation of mitogen-activated protein kinases in experimental mesangioproliferative glomerulonephritis | Q73426407 | ||
| Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis | Q74086765 | ||
| Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase | Q74607823 | ||
| Effective accumulation of polyion complex micelle to experimental choroidal neovascularization in rats | Q75326073 | ||
| Activation of mesangial cell signaling cascades in response to mechanical strain | Q78163813 | ||
| p38 Mitogen-activated protein kinase contributes to autoimmune renal injury in MRL-Fas lpr mice | Q78728968 | ||
| P433 | issue | 4 | |
| P921 | main subject | glomerulonephritis | Q605006 |
| P304 | page(s) | 622-633 | |
| P577 | publication date | 2010-03-04 | |
| P1433 | published in | Journal of the American Society of Nephrology | Q17123893 |
| P1476 | title | siRNA-based therapy ameliorates glomerulonephritis | |
| P478 | volume | 21 |
| Q41896485 | Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation |
| Q34076025 | Applications of proteomic technologies for understanding the premature proteolysis of CFTR. |
| Q89296976 | Design and evaluation of glomerulus mesangium-targeted PEG-PLGA nanoparticles loaded with dexamethasone acetate |
| Q24295031 | Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect |
| Q27010574 | Fighting against kidney diseases with small interfering RNA: opportunities and challenges |
| Q35622475 | Impairment of hepatic nuclear factor-4α binding to the Stim1 promoter contributes to high glucose-induced upregulation of STIM1 expression in glomerular mesangial cells |
| Q48093995 | In Vivo siRNA Delivery and Rebound of Renal LRP2 in Mice. |
| Q50877858 | Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice. |
| Q30389264 | Kidney-specific Sonoporation-mediated Gene Transfer |
| Q38964991 | Liver transplantation in transthyretin amyloidosis: Characteristics and management related to kidney disease. |
| Q30429535 | Mesangial pathology in glomerular disease: targets for therapeutic intervention |
| Q38115932 | MicroRNAs in kidney diseases: new promising biomarkers for diagnosis and monitoring |
| Q48630939 | Modulating the immune system through nanotechnology. |
| Q38862723 | Nanomedicines for kidney diseases |
| Q37879444 | New short interfering RNA-based therapies for glomerulonephritis |
| Q30427986 | Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice |
| Q37015817 | Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides |
| Q104064431 | SHROOM3, the gene associated with chronic kidney disease, affects the podocyte structure |
| Q39301867 | Single siRNA nanocapsules for enhanced RNAi delivery |
| Q36223317 | Store-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression |
| Q92727723 | Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo |
| Q42376017 | Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis |
| Q91555360 | The effectiveness of chitosan-mediated silencing of PDGF-B and PDGFR-β in the mesangial proliferative glomerulonephritis therapy |
| Q38287288 | Transcription factors and epigenetic modulation: its therapeutic implication in chronic kidney disease |
| Q35224125 | siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA |
| Q38191482 | siRNA technology in kidney transplantation: current status and future potential |
| Q42905735 | siRNAs targeted to Smad4 prevent renal fibrosis in vivo |
Search more.